NGNE insider trading — Neurogene Inc.
No open-market insider purchases or sales were filed for Neurogene Inc. (NGNE) in the last 90 days. Other insider transactions — such as stock awards, option exercises or tax withholding — are listed below.
Updated Oct 16, 2026.
Recent NGNE insider transactions
Every Form 4 filed by Neurogene Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | Mcminn Rachel | Chief Executive Officer | M · Option exercise | Direct | 756 | $25.32 | $19K | Form 4 |
NGNE insider trading FAQ
Are insiders buying NGNE stock?
Not on the open market. In the last 90 days, Neurogene Inc. insiders made no open-market purchases, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading NGNE?
No insider bought or sold on the open market in the last 90 days.
Where does NGNE insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.